1. Home
  2. EVC vs FDMT Comparison

EVC vs FDMT Comparison

Compare EVC & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Entravision Communications Corporation

EVC

Entravision Communications Corporation

N/A

Current Price

$7.39

Market Cap

683.9M

Sector

Industrials

ML Signal

N/A

Logo 4D Molecular Therapeutics Inc.

FDMT

4D Molecular Therapeutics Inc.

N/A

Current Price

$13.93

Market Cap

695.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EVC
FDMT
Founded
1996
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
683.9M
695.3M
IPO Year
2000
2019

Fundamental Metrics

Financial Performance
Metric
EVC
FDMT
Price
$7.39
$13.93
Analyst Decision
Strong Buy
Analyst Count
0
12
Target Price
N/A
★ $27.82
AVG Volume (30 Days)
★ 935.3K
773.8K
Earning Date
11-03-2026
11-09-2026
Dividend Yield
★ 2.72%
N/A
EPS Growth
★ 47.59
18.79
EPS
★ 0.32
N/A
Revenue
★ $536,034,000.00
$85,209,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$56.84
P/E Ratio
$23.20
★ N/A
Revenue Growth
N/A
★ 230194.60
52 Week Low
$1.95
$6.96
52 Week High
$13.74
$16.93

Technical Indicators

Market Signals
Indicator
EVC
FDMT
Relative Strength Index (RSI) 30.58 50.33
Support Level $2.89 $13.39
Resistance Level $10.09 $15.29
Average True Range (ATR) 0.29 0.88
MACD -0.01 -0.12
Stochastic Oscillator 7.01 37.21

Price Performance

Historical Comparison
EVC
FDMT

About EVC Entravision Communications Corporation

Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the advertising and technology services segment. Geographically, the company generates the majority of its revenue from the United States.

About FDMT 4D Molecular Therapeutics Inc.

4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).

Share on Social Networks: